Stock Scorecard



Stock Summary for Mannkind Corp (MNKD) - $3.71 as of 5/29/2026 9:21:43 AM EST

Total Score

5 out of 30

Safety Score

25 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for MNKD

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for MNKD

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for MNKD

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for MNKD

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for MNKD (25 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 4
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for MNKD

FDA drops MannKind (NASDAQ: MNKD) Afrezza pulmonary malignancy trial demand 5/28/2026 12:11:00 PM
MannKind to Present at Jefferies Global Healthcare Conference 5/28/2026 12:11:00 AM
MannKind CEO joins Jefferies healthcare investor conference June 3 5/27/2026 8:09:00 PM
MannKind to Present at Jefferies Global Healthcare Conference 5/27/2026 8:09:00 PM
MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems 5/27/2026 1:09:00 PM
MannKind to Showcase New Data at ADA 2026 Advancing 5/27/2026 12:11:00 PM
MNKD Stock Heads For Strongest Month In Over Three Years As FDA Catalyst Draws Closer 5/26/2026 12:11:00 PM
MannKind (MNKD) director Jennifer Grancio granted 82,781 restricted stock units 5/23/2026 11:09:00 PM
MannKind director (MNKD) awarded stock and RSUs, updates holdings 5/23/2026 10:41:00 PM
MannKind Corporation 8-K Filing Details Board Election Results and Company Information (May 2026) 5/23/2026 9:12:00 AM

Financial Details for MNKD

Company Overview

Ticker MNKD
Company Name Mannkind Corp
Country USA
Description MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutics for endocrine and orphan lung diseases in the United States. The company is headquartered in Westlake Village, California.
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 3/31/2026
Next Earnings Date 8/5/2026

Stock Price History

Last Day Price 3.71
Price 4 Years Ago 5.27
Last Day Price Updated 5/29/2026 9:21:43 AM EST
Last Day Volume 3,704,851
Average Daily Volume 5,823,886
52-Week High 6.51
52-Week Low 2.23
Last Price to 52 Week Low 66.37%

Valuation Measures

Trailing PE N/A
Industry PE 108.94
Sector PE 66.00
5-Year Average PE -24.00
Free Cash Flow Ratio 21.82
Industry Free Cash Flow Ratio 25.30
Sector Free Cash Flow Ratio 34.59
Current Ratio Most Recent Quarter 1.87
Total Cash Per Share 0.17
Book Value Per Share Most Recent Quarter -0.19
Price to Book Ratio 187.85
Industry Price to Book Ratio 15.24
Sector Price to Book Ratio 23.00
Price to Sales Ratio Twelve Trailing Months 3.04
Industry Price to Sales Ratio Twelve Trailing Months 13.16
Sector Price to Sales Ratio Twelve Trailing Months 5.25
Analyst Buy Ratings 7
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 308,950,000
Market Capitalization 1,146,204,500
Institutional Ownership 59.28%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 1.25%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -34.90%
Annual Earnings Growth -78.75%
Reported EPS 12 Trailing Months -0.07
Reported EPS Past Year -0.02
Reported EPS Prior Year 0.17
Net Income Twelve Trailing Months -23,914,000
Net Income Past Year 5,863,000
Net Income Prior Year 27,588,000
Quarterly Revenue Growth YOY 15.10%
5-Year Revenue Growth 39.89%
Operating Margin Twelve Trailing Months -3.31%

Balance Sheet

Total Cash Most Recent Quarter 52,834,000
Total Cash Past Year 74,882,000
Total Cash Prior Year 46,339,000
Net Cash Position Most Recent Quarter -265,888,000
Net Cash Position Past Year -243,479,000
Long Term Debt Past Year 318,361,000
Long Term Debt Prior Year 36,051,000
Total Debt Most Recent Quarter 318,722,000
Equity to Debt Ratio Past Year -0.19
Equity to Debt Ratio Most Recent Quarter -0.23
Total Stockholder Equity Past Year -51,022,000
Total Stockholder Equity Prior Year -78,816,000
Total Stockholder Equity Most Recent Quarter -59,195,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 12,718,000
Free Cash Flow Per Share Twelve Trailing Months 0.04
Free Cash Flow Past Year 13,689,000
Free Cash Flow Prior Year 32,818,000

Options

Put/Call Ratio 0.08
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 1.04
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 5/28/2026 8:09:53 PM EST